Duke Street Bio, a London based biotech focusing on the discovery of novel precision medicine-based cancer therapies, today strengthens its executive leadership team with the appointment of Jeff Thompson, PhD, MBA, as Head of Clinical Operations.

Duke Street Bio has strengthed its executive leadership team with the appointment of Dónal Landers, MB BCh BAO, MBA, DPM, FFPM as Chief Medical Officer.